4 completed, 3 terminated, 1 available. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow ZevraDenmark: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial Arimoclomol - Amyotrophic Lateral Sclerosis | Phase 3 | Terminated | ZevraDenmark | 120 | 2019-09-19 | 2023-08-24 |
| Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial Arimoclomol - Inclusion Body Myositis | Phase 3 | Terminated | ZevraDenmark | 121 | 2019-05-20 | 2023-09-15 |
| Arimoclomol in Amyotropic Lateral Sclerosis Arimoclomol, Placebo - Amyotrophic Lateral Sclerosis | Phase 3 | Completed | ZevraDenmark | 245 | 2018-07-31 | 2023-08-24 |
| Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3 Arimoclomol, Placebo oral capsule - Gaucher Disease, Type 1, Gaucher Disease, Type 3 | Phase 2 | Terminated | ZevraDenmark | 39 | 2018-06-06 | 2023-01-11 |
| Study of Arimoclomol in Inclusion Body Myositis (IBM) Arimoclomol, Placebo - Inclusion Body Myositis | Phase 2 | Completed | ZevraDenmark | 152 | 2017-08-16 | 2023-05-10 |
| Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C arimoclomol, Placebo - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | ZevraDenmark | 50 | 2016-06-14 | 2024-11-29 |
| A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C Niemann-Pick Disease, Type C | Completed | ZevraDenmark | 35 | 2015-09-01 | 2017-05-18 | |
| Early Access Program With Arimoclomol in US Patients With NPC Arimoclomol - Niemann-Pick Disease, Type C | Available | ZevraDenmark | 2024-08-16 |
Niemann-Pick Disease, Type C (3) · Amyotrophic Lateral Sclerosis (2) · Lysosomal Storage Diseases (2) · Myositis, Inclusion Body (2) · Gaucher Disease (1)
arimoclomol (7)
United Kingdom (6) · United States (6) · France (4) · Germany (4) · Italy (4) · Poland (4) · Spain (4) · Switzerland (3) · Belgium (2) · Canada (2) · Denmark (2) · Netherlands (2) · Sweden (2) · India (1)
Karl-Eugen Mengel (2) · Michael Benatar, MD PhD (2) · Aabha Nagral, MD (1) · Mazen Dimachkie, MD (1) · Mazen M Dimachkie (1) · Michael Hanna (1) · Michael Hanna, MD (1)
PMID 33228797, PMID 34418116, PMID 37739573, PMID 38782015, PMID 38960586
2014 (1)